Top Tweets for #Krazati
Adagrasib 200 mg is a targeted KRAS G12C inhibitor used for the treatment of mutation-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior therapy. https://t.co/Z7PgWGxX2N #Adagrasib #Krazati #KRASG12C #NSCLC #LungCancer #PrecisionOncology
BMS Announces FDA Accelerated Approval of #Krazati (adagrasib) in Combination with Cetuximab for Previously Treated KRAS G12C-Mutated Locally Advanced or Metastatic Colorectal Cancer https://t.co/obfRw48FCD
#KRAZATI Shows Notable Progression-Free Survival Improvement in Advanced or Metastatic KRASG12C-Mutated #NSCLC Patients
https://t.co/vT1CSXLiiu
#ASCO24 #ASCO2024 #OncoAlert #pharma #pharmaceutical #Science #MedComms #healthcare #MedicalAffairs #NovartisNews #news #media #breaking
$SNY looking at $MRTX for #Krazati KRAS #lungcancer drug. Those w/ concerns of size of #PTCL for $CRVS take notice, cases w/ KRAS G12C mutation only 15k patients in US.
$CRVS PTCL by comparison has 18k cases in US.
Market Cap $MRTX $4.2bn... $CRVS $75mn
https://t.co/ncwcL1M3h9
FDA Convenes Advisors To Assess Full Approval Prospects For Amgen’s Lumakras Amid KRAS Uncertainties
Read More: https://t.co/xbOOjvdwc6
#pharmanews #pharmaupdates #Pharmtales
#FDA #Amgen #KRASG12Cmutation #KRASinhibitor, #KRASmutation #krazati #Lumakras #NSCLC #lifesciences
#Adagrasib (#Krazati) demonstrated antitumor activity in heavily pretreated patients with KRAS G12C-mutated, metastatic #colorectalcancer, reported @RonaYaeger, MD, of @MSKCancerCenter.
https://t.co/tGTf84hgQI #OncTwitter #MedTwitter #GITwitter @medpagetoday
Mirati、ゴールしてからの長旅
#Mirati の #Kras阻害剤 #adagrasib (#Krazati)の迅速承認は、株価を上げずむしろ下落させた。Miratiが優位に立つチャンスはあるが、確認試験には時間がかかり、よりリスクが高くなる懸念がある。
https://t.co/26ztTeLIrN
#Evaluate
The @US_FDA has granted accelerated approval to #adagrasib (#Krazati) for patients w/ KRAS G12C–mutated locally advanced or metastatic non–small cell #lungcancer, as determined by an FDA-approved test, who have received 1+ prior systemic therapy. #lcsm https://t.co/VFgM4v5XfT
في تطور علمي مذهل ل #سرطان_الرئة وافقت ال FDA على دواء #adagrasib
#Krazati الذي يعمل كدواء جيني موجه على الطفرة الجينية KRAS G12C الذي يتحكم في تكاثر الخلايا
علما بان تكلفه الجرعة الشهريه تعادل 19750$
للمزيد حول ذلك
https://t.co/VK3A6F7yMQ
FDA approval News: Congratulations! #Krazati (#adagrasib) gets US approval as targeted option for #KRAS G12C-mutated #NSCLC.
@Mirati
#BioPharma #Pharma #STEM #Therapeutics #PatientsFirst #DrugDevelopment #FDAapproved #LCSM #lungcancer
Read more here: https://t.co/Tk2FZj7UkZ
#KRAZATI Accelerated Approval of KRAZATI™ #adagrasib as a Targeted Treatment Option for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer 🫁 #NSCLC with a #KRAS G12C Mutation
Last Seen Hashtags on Sotwe
yerimuavideo
Seen from Mexico
劫持
Seen from Thailand
Beurette
Seen from Netherlands
เอาตูด
Seen from Thailand
黒ソ
Seen from Japan
suegra
Seen from United States
lewd
Seen from Netherlands
ExpatPanama
Seen from United States
anxiouspanda
Seen from United States
mgai()(filter:videos)
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.6M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers